Butyrate derivatives from probiotics negatively regulate the NLRP3-mediated inflammatory signaling pathway, inhibit the activation of associated macrophages, and reduce their expression levels of PD-L1 and IL-10, thereby suppressing tumor growth in mice (Yao et al., 2022; Lee et al., 2024). Here, IL10 is linked to neoplasm.